From injection to pill: how do we make access to obesity medicine more equitable? (opens in new tab)
The UK has just become the first country in Europe to approve oral semaglutide. What happens next at NICE will either close one of the biggest health inequality gaps in modern Britain or widen it dramatically.
Read the original article